Want to join the conversation?
$PPS raised its 2016 EPS guidance to $1.45-1.51 from previous forecast of $1.37-1.49 and its funds from operations per share outlook to range of $3.20-3.24 from prior estimate of $3.12-3.22. The company lifted its 2016 revenue growth projection to 3-3.3% from 2.8-3.2% and net operating income growth estimate to 2.5-3.3% from 2.1-3.1%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?